# § 520.260   

(a) *Specifications.* Each capsule contains 221, 442, 884, or 1,768 milligrams (mg); or 4.42 grams of *n*-butyl chloride.


(b) *Sponsors.* See sponsors in § 510.600(c) of this chapter:


(1) No. 023851 for capsules containing 221, 442, 884, or 1,768 mg, or 4.42 grams (g); and


(2) No. 054771 for capsules containing 221 mg.


(c) *Conditions of use in dogs*—(1) *Amount.* Administer capsules orally based on body weight as follows:


(i) Capsules containing 221 mg: Under 5 pounds, 1 capsule per 1
1/4 pounds of body weight.


(ii) Capsules containing 442 mg: Under 5 pounds, 1 capsule per 2
1/2 pounds of body weight.


(iii) Capsules containing 884 mg:


(A) Under 5 pounds, 1 capsule;


(B) 5 to 10 pounds, 2 capsules;


(C) 10 to 20 pounds, 3 capsules;


(D) 20 to 40 pounds, 4 capsules;


(E) Over 40 pounds, 5 capsules.


(iv) Capsules containing 1,768 mg: Dogs weighing 5 to 10 pounds, 1 capsule.


(v) Capsules containing 4.42 g: Dogs weighing 40 pounds or over, 1 capsule.


(2) *Indications for use.* For the removal of ascarids (*Toxocara canis* and *Toxascaris leonina*) and hookworms (*Ancylostoma caninum, Ancylostoma braziliense,* and *Uncinaria stenocephala*) from dogs.


(3) *Limitations.* Dogs should not be fed for 18 to 24 hours before being given the drug. Administration of the drug should be followed in 
1/2 to 1 hour with a mild cathartic. Normal feeding may be resumed 4 to 8 hours after treatment. Animals subject to reinfection may be retreated in 2 weeks. A veterinarian should be consulted before using in severely debilitated dogs.



---

[N] [86 FR 10819, Feb. 23, 2021]







 



 








